Form 4: HCSG Director Elects Stock for Board Fees

Healthcare Services Group Director Thomas Whalen acquired 149 shares of common stock by electing to receive Deferred Stock Units in lieu of cash fees for board service.

Summary

• Thomas Gerard Whalen, a Director of Healthcare Services Group Inc. (HCSG), acquired 149 shares of common stock.
• The transaction occurred on September 30, 2025, at a price of $16.83 per share.
• This acquisition was a result of Mr. Whalen's election in May 2025 to receive fully vested Deferred Stock Units (DSUs) under the Issuer's 2020 Omnibus Incentive Plan, in lieu of cash fees for his service on the Board of Directors.
• The number of shares was determined by dividing the amount of fees by the Issuer's closing stock price on the payment date, rounded up.
• Following this transaction, Mr. Whalen beneficially owns 3,020 shares, comprising 2,806 unvested DSUs and 214 vested DSUs.
• The DSUs will be settled in shares of common stock ninety days following his separation from the Board, with an option for further deferral under Code Section 409A rules.

Sentiment

Score: 7

Explanation: The sentiment is positive as the director's decision to receive equity compensation aligns his interests with shareholders, indicating confidence in the company's long-term prospects. This is a routine, pre-planned transaction, not indicative of new fundamental news, but generally viewed as a good governance practice.

Positives

• The director's election to receive equity instead of cash for board service increases his alignment with shareholder interests.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned and systematic approach to equity compensation.

Future Outlook

The Deferred Stock Units (DSUs) acquired will be settled in shares of common stock ninety days following the director's separation of service from the Board. The reporting person has the option to elect a further deferral beyond this settlement date, in compliance with Code Section 409A rules.

Management Comments

• The reporting person has elected to receive fully vested shares of Deferred Stock Units ('DSUs') under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof.
• The election was made in May 2025, applying to director's fees earned in 2025, in compliance with the Issuer's black-out period guidelines.
• The number of shares represents the quotient of the amount of such fees divided by the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share.

Industry Context

The practice of directors electing to receive equity compensation, such as Deferred Stock Units, in lieu of cash fees is a common corporate governance practice across various industries. It is often viewed favorably as it aligns the interests of the board members with those of the shareholders by increasing their direct stake in the company's performance.

Comparison to Industry Standards

• The election by a director to receive equity (DSUs) instead of cash for board service is a standard practice in corporate governance, aligning director incentives with shareholder value creation.
• Many publicly traded companies, including peers in the healthcare services sector, offer similar equity-based compensation plans to their non-employee directors to foster long-term commitment and performance alignment.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to equity-based compensation, potentially fostering more shareholder-centric decision-making.
• Board of Directors: The compensation structure encourages long-term commitment and performance focus among board members.

Next Steps

• Settlement of the Deferred Stock Units (DSUs) into common stock shares ninety days following the director's separation from the Board.
• Potential for the reporting person to elect a further deferral of DSU settlement beyond the initial 90-day period, pursuant to Code Section 409A rules.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider transaction where a director elected to receive equity compensation instead of cash. While this practice is generally positive for corporate governance and shareholder alignment, it does not present new material information that would fundamentally alter the investment thesis for Healthcare Services Group Inc. Therefore, a 'hold' recommendation is appropriate, as the filing does not provide a basis for a change in existing investment positions.

Keywords

Healthcare Services Group, HCSG, Insider Transaction, Form 4, Director Compensation, Deferred Stock Units, Equity Compensation, Corporate Governance